VetCPD is grateful for the support of the following companies
Shop
← Continue Shopping

Treating Canine Lymphoma in General Practice

£15.00 + VAT

Vol 6 - Issue 4
Written by Isabelle Desmas-Bazelle DVM MVetMed MRCVS DipAVCIM (Onc) American Specialist in Veterinary Oncology
ADD TO BASKETPREVIEW


NB: Please choose the number of students above, then enter each delegates details below, before adding to basket.
Categories: ,

Treating Canine Lymphoma in General Practice

Canine lymphoma is one of the most common, and best documented, neoplasms

in veterinary medicine with many patients managed in general practice. Lymphoma

is generally very sensitive to chemotherapy and a rewarding disease to treat.

Whilst the diagnosis can often be established cytologically, histological assessment

provides further classification. Immunophenotyping (to characterise disease as of

B or T cell origin) is recommended and can be achieved via immunohistochemistry,

flow cytometry or PCR for antigen rearrangement (PARR). Ideally, staging should

be performed at the time of the initial diagnosis and should include thoracic and

abdominal imaging as well as bone marrow assessment. There are many different

types of lymphoma with different clinical courses and variable prognoses so initial

characterisation of each individual case is essential in guiding the treatment plan.

High grade B cell multicentric lymphoma is most commonly encountered and has

an expected survival time of 10 to 12 months when treated with chemotherapy.

Multidrug chemotherapy protocols are the mainstay of treatment and CHOP and

LOPP regimens are recommended as first-line treatment for high grade multicentric

lymphoma. However, many alternative protocols are available and can be used to

overcome any time and financial constraints the client might have.

All our Tutored Online CPD Courses are written and taught by an expert in the relevant field. The tutor for this course is:

Isabelle Desmas-Bazelle DVM MVetMed MRCVS DipAVCIM (Onc) American Specialist in Veterinary Oncology

1